Uterine Cervical Neoplasms Clinical Trial
Official title:
Prospective Randomized Trial on2D Versus 3D Laparoscopic Radical Hysterectomy With Pelvic Lymphadenectomy for the Treatment of Early Stage Cervical Cancer (FIGO Stages IA2-IB1-IIA<2cm) and Advanced Stage Cervical Cancer (FIGO Stages IB2-IIA>2 Cm-IIB) Submitted to NACT With Complete Clinical Response.
The aim of this prospective randomized pilot study is to verify if the operative time of a Radical abdominal hysterectomy (LRH) with pelvic lymphadenectomy for early stage cervical cancer (FIGO stages IA2-IB1-IIA<2cm) and for advanced stage cervical cancer (FIGO stages IB2-IIA>2cm-IIB) submitted to neoadjuvant chemotherapy (NACT) with complete clinical response could be further reduced using 3D Laparoscopy (Olympus Medical Systems Corp) versus standard laparoscopy
Radical abdominal hysterectomy (RAH) with pelvic lymphadenectomy is the standard surgical
treatment for early stage cervical carcinoma FIGO stages IA2-IB1-IIA<2cm. Since the early
90's laparoscopic radical hysterectomy with pelvic lymphadenectomy (LRH) has been suggested
as surgical approach for the treatment of cervical cancer. In the recent years, many
institutions have begun to consider it an attractive technique and to study its feasibility
and safety. Most of these studies have shown that LRH is relatively more time-consuming than
standard laparotomy and ranges from 90 to 420 minutes according to surgeons' experience and
different techniques adopted to achieve hemostasis, resect the parametrium and uterosacrals.
Spirtos et al. demonstrated that staplers could reduce mean operation time from 253 to 205
minutes if compared to argon beam coagulator. Moreover, the pulsed bipolar system was
associated with significant reduction in operative time in comparison with the conventional
bipolar system (mean, 172 minutes vs 229 minutes; P < 0.001). The largest series of LRH
reported from a single institution by Puntambekar et al included 248 patients and described
the "Pune technique" (anterior and posterior peritoneal U cuts, early dissection of the
rectovaginal space, fully mobilization of the uterus, resection of the cardinal and
uterosacral ligaments with Ligasure system (Ligasure Vessel Sealing System; Valleylab, Tyco
Healthcare, Boulder, CO)), obtaining a very short mean operative time (mean, 92 minutes;
range 6-120 minutes).
A recent review on laparoscopic and robot-assisted radical hysterectomy with pelvic
lymphadenectomy including 17 studies reported a mean operating time of 202 minutes [range,
184-221 minutes] in the group of LRH, which matches with our experience of 210 min (range
180-240), using conventional bipolar electrosurgery.
This prospective randomized pilot study is aimed to verify if the operative time of a LRH
with pelvic lymphadenectomy for early stage cervical cancer (FIGO stages IA2-IB1-IIA<2cm)
and for advanced stage cervical cancer (FIGO stages IB2-IIA>2cm-IIB) submitted to
neoadjuvant chemotherapy (NACT) with complete clinical response could be further reduced
using 3D Laparoscopy (Olympus Medical Systems Corp) vs. standard laparoscopy.
Saving operative time would mean shorter anesthesia and faster recovery, further improving
the safety profile of the laparoscopic approach in the treatment of cervical cancer.
Secondary endopoints of this comparison are incidence of intra- or postoperative
complications (Cardiac, Respiratory, Neurological, Gastrointestinal, Renal, Fever, Wound or
other Infection, Lymphocele), estimated blood loss, days of hospitalization and costs for
the health care system.
;
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03225443 -
Observation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Particle Radiotherapy Versus Neoadjuvant Chemotherapy
|
N/A | |
Recruiting |
NCT01373723 -
Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer
|
N/A | |
Terminated |
NCT01194609 -
A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT02808832 -
An HPV Vaccine Provider Intervention in Safety Net Clinics
|
N/A | |
Terminated |
NCT01234480 -
Intended Use Study of the BD SurePath Plus™ Pap
|
||
Terminated |
NCT01075412 -
FLT PET Imaging for Cervical Cancer
|
Phase 2 | |
Completed |
NCT01014026 -
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
|
Phase 3 | |
Completed |
NCT02865889 -
Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications
|
N/A | |
Completed |
NCT00377845 -
Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.
|
Phase 0 | |
Recruiting |
NCT05531981 -
Detection of Minimal Residual Disease Based on HPV ctDNA in Cervical Cancer
|
||
Recruiting |
NCT05393440 -
First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer
|
Phase 1 | |
Recruiting |
NCT05007106 -
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
|
Phase 2 | |
Completed |
NCT02866006 -
Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03270995 -
Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study
|
N/A | |
Terminated |
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
||
Not yet recruiting |
NCT05065853 -
Urinary and Vaginal HPV Testing in Cervical Cancer Screening
|
||
Completed |
NCT01231945 -
Low-Cost Molecular Cervical Cancer Screening Study
|
N/A | |
Completed |
NCT01717391 -
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
|
Phase 2 | |
Active, not recruiting |
NCT04947605 -
Epidemiological Landscape of Cervical Cancer in Latin America
|
||
Recruiting |
NCT06124040 -
Sexual Function, Coping and Dyadic Coping in Patients With Cervical Cancer
|